A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia.
about
A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@en
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@nl
type
label
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@en
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@nl
prefLabel
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@en
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@nl
P2093
P2860
P356
P1476
A nitroimidazole derivative, P ...... ose irradiation under hypoxia.
@en
P2093
Eishi Nagai
Kazuhiro Mizumoto
Li-Wu Qian
Masao Tanaka
Shinobu Kura
P2860
P356
10.1269/JRR.43.43
P577
2002-03-01T00:00:00Z